248652055	248652055	CD	B-NP	O
|	|	NNP	I-NP	O
VAEHCS	VAEHCS	NNP	I-NP	O
|	|	VBD	B-VP	O
07563073	07563073	CD	B-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
3820514	3820514	CD	B-NP	O
|	|	CC	I-NP	O
8/29/2005	8/29/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Summary	Summary	NNP	I-NP	O
|	|	NNP	I-NP	O
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
1/23/2005	1/23/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
ATTENDING	ATTENDING	NNP	B-NP	O
:	:	:	O	O
DORIAN	DORIAN	NNP	B-NP	O
SPORN	SPORN	NNP	I-NP	O
MD	MD	NNP	I-NP	O
ADMITTING	ADMITTING	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
Congestive	Congestive	JJ	B-NP	O
iheart	iheart	NN	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
Pending	Pending	NNP	B-NP	O
.	.	.	O	O

CHIEF	CHIEF	NN	B-NP	B-protein
COMPLAINT	COMPLAINT	NN	I-NP	O
:	:	:	O	O
Bloating	Bloat	VBG	B-VP	O
,	,	,	O	O
abdominal	abdominal	JJ	B-NP	O
distention	distention	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
56-year-old	56-year-old	JJ	I-NP	O
woman	woman	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
idiopathic	idiopathic	JJ	I-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
EF	EF	NN	I-NP	O
of	of	IN	B-PP	O
15	15	CD	B-NP	O
%	%	NN	I-NP	O
who	who	WP	B-NP	O
presents	present	VBZ	B-VP	O
with	with	IN	B-PP	O
bloating	bloat	VBG	B-NP	O
,	,	,	O	O
abdominal	abdominal	JJ	B-NP	O
distention	distention	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
fatigue	fatigue	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
idiopathic	idiopathic	JJ	I-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
was	be	VBD	B-VP	O
diagnosed	diagnose	VBN	I-VP	O
in	in	IN	B-PP	O
1990	1990	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
Chronicle	Chronicle	NNP	I-NP	O
device	device	NN	I-NP	O
to	to	TO	B-VP	O
monitor	monitor	VB	I-VP	O
filling	filling	NN	B-NP	O
pressures	pressure	NNS	I-NP	O
placed	place	VBN	B-VP	O
in	in	IN	B-PP	O
2001	2001	CD	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
nonfunctional	nonfunctional	JJ	B-ADJP	O
since	since	IN	B-PP	O
2004	2004	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
worsening	worsen	VBG	I-VP	O
symptoms	symptom	NNS	B-NP	O
in	in	IN	B-PP	O
September	September	NNP	B-NP	O
2004	2004	CD	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
led	lead	VBD	B-VP	O
to	to	TO	B-PP	O
an	an	DT	B-NP	O
admission	admission	NN	I-NP	O
for	for	IN	B-PP	O
diuresis	diuresis	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
showed	show	VBD	B-VP	O
evidence	evidence	NN	B-NP	O
of	of	IN	B-PP	O
fluid	fluid	NN	B-NP	O
overload	overload	NN	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
of	of	IN	B-PP	O
diuresis	diuresis	NN	B-NP	O
with	with	IN	B-PP	O
IV	IV	CD	B-NP	O
Lasix	Lasix	NNP	I-NP	O
and	and	CC	O	O
IV	IV	CD	B-NP	O
dobutamine	dobutamine	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
developed	develop	VBD	B-VP	O
a	a	DT	B-NP	O
Chronicle	Chronicle	NNP	I-NP	O
device	device	NN	I-NP	O
lead	lead	NN	I-NP	O
thrombus	thrombus	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
anticoagulation	anticoagulation	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
underwent	undergo	VBD	B-VP	O
a	a	DT	B-NP	O
right	right	JJ	I-NP	O
heart	heart	NN	I-NP	O
cath	cath	NN	I-NP	O
in	in	IN	B-PP	O
September	September	NNP	B-NP	O
2004	2004	CD	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
an	an	DT	B-NP	O
artery	artery	NN	I-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
10	10	CD	B-NP	O
,	,	,	O	O
wedge	wedge	JJ	B-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
25	25	CD	B-NP	O
,	,	,	O	O
SVR	SVR	NN	B-NP	O
2074	2074	CD	I-NP	O
,	,	,	O	O
PVR	PVR	NN	B-NP	B-protein
326	326	CD	I-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
CI	CI	NN	B-NP	O
of	of	IN	B-PP	O
1.5	1.5	CD	B-NP	O
.	.	.	O	O

Post-diuresis	Post-diuresis	NN	B-NP	O
after	after	IN	B-PP	O
addition	addition	NN	B-NP	O
of	of	IN	B-PP	O
hydralazine	hydralazine	NN	B-NP	O
and	and	CC	I-NP	O
Isordil	Isordil	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
RA	RA	NN	I-NP	O
pressures	pressure	NNS	I-NP	O
were	be	VBD	B-VP	O
RA	RA	NN	B-NP	B-protein
=	=	SYM	B-VP	I-protein
8	8	CD	B-NP	I-protein
,	,	,	O	O
pulmonary	pulmonary	JJ	B-NP	O
artery	artery	NN	I-NP	O
=	=	SYM	B-VP	O
50/24	50/24	CD	B-NP	O
,	,	,	O	O
cardiac	cardiac	JJ	B-NP	O
index	index	NN	I-NP	O
of	of	IN	B-PP	O
2.4	2.4	CD	B-NP	O
with	with	IN	B-PP	O
SVR	SVR	NN	B-NP	B-protein
of	of	IN	B-PP	O
1205	1205	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	'	VBZ	I-NP	O
most	most	RBS	B-NP	O
recent	recent	JJ	I-NP	O
admission	admission	NN	I-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
August	August	NNP	B-NP	O
2004	2004	CD	I-NP	O
with	with	IN	B-PP	O
decompensated	decompensate	VBN	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
during	during	IN	B-PP	O
which	which	WDT	B-NP	O
time	time	NN	I-NP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
diuresed	diurese	VBN	I-VP	O
with	with	IN	B-PP	O
IV	IV	NNP	B-NP	O
Lasix	Lasix	NNP	I-NP	O
,	,	,	O	O
metolazone	metolazone	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
dobutamine	dobutamine	NN	B-NP	O
and	and	CC	O	O
diuresed	diurese	VBD	B-VP	O
11	11	CD	B-NP	O
liters	liter	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
began	begin	VBD	B-VP	O
workup	workup	NN	B-NP	O
for	for	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	O
transplant	transplant	NN	I-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
on	on	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
describes	describe	VBZ	B-VP	O
one	one	CD	B-NP	O
week	week	NN	I-NP	O
of	of	IN	B-PP	O
abdominal	abdominal	JJ	B-NP	O
distention	distention	NN	I-NP	O
,	,	,	O	O
lower	low	JJR	B-NP	O
extremity	extremity	NN	I-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
stable	stable	JJ	B-NP	O
two-pillow	two-pillow	JJ	I-NP	O
orthopnea	orthopnea	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
describes	describe	VBZ	B-VP	O
no	no	DT	B-NP	O
PND	PND	NN	I-NP	B-protein
,	,	,	O	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
palpitations	palpitation	NNS	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
denies	deny	VBZ	B-VP	O
dietary	dietary	JJ	B-NP	O
or	or	CC	I-NP	O
med	me	VBN	I-NP	O
noncompliance	noncompliance	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
As	As	IN	B-ADVP	O
above	above	RB	I-ADVP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Glyburide	Glyburide	NN	B-NP	O
10	10	CD	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
a.m.	a.m.	NN	I-NP	O
and	and	CC	O	O
5	5	CD	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
p.m.	p.m.	NN	I-NP	B-DNA
2	2	CD	I-NP	I-DNA
.	.	.	O	O

Digoxin	Digoxin	NN	B-NP	O
0.125	0.125	CD	I-NP	O
q.d.	q.d.	NN	I-NP	O
3	3	CD	I-NP	O
.	.	.	O	O

Probenecid	Probenecid	NN	B-NP	B-protein
500	500	CD	I-NP	I-protein
q.d.	q.d.	NN	I-NP	I-protein
4	4	CD	I-NP	I-protein
.	.	.	O	O

Multivitamin	Multivitamin	NN	B-NP	B-protein
one	one	CD	I-NP	I-protein
tab	tab	NN	I-NP	I-protein
q.d.	q.d.	NN	I-NP	I-protein
5	5	CD	I-NP	I-protein
.	.	.	O	O

KCL	KCL	NN	B-NP	O
20	20	CD	I-NP	O
mEq	mEq	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
6	6	CD	I-NP	O
.	.	.	O	O

Celexa	Celexa	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
7	7	CD	I-NP	O
.	.	.	O	O

Hydralazine	Hydralazine	NN	B-NP	B-protein
100	100	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
p.o.	p.o.	NN	I-NP	I-protein
t.i.d.	t.i.d.	NN	I-NP	I-protein
8	8	CD	I-NP	I-protein
.	.	.	O	O

Ativan	Ativan	IN	B-PP	O
0.5	0.5	CD	B-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
9	9	CD	I-NP	O
.	.	.	O	O

Coumadin	Coumadin	NN	B-NP	O
5	5	CD	I-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
10	10	CD	I-NP	O
.	.	.	O	O

Isordil	Isordil	NN	B-NP	O
40	40	CD	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
11	11	CD	I-NP	O
.	.	.	O	O

Torsemide	Torsemide	NN	B-NP	O
200	200	CD	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
12	12	CD	I-NP	O
.	.	.	O	O

Lisinopril	Lisinopril	NNP	B-NP	O
2.5	2.5	CD	I-NP	O
q.d.	q.d.	NN	I-NP	O
SOCIAL	SOCIAL	NN	I-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
lives	live	VBZ	B-VP	O
with	with	IN	B-PP	O
three	three	CD	B-NP	O
daughters	daughter	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
ex-custodian	ex-custodian	JJ	I-NP	O
with	with	IN	B-PP	O
past	past	JJ	B-NP	O
tobacco	tobacco	NN	I-NP	O
use	use	NN	I-NP	O
but	but	CC	O	O
no	no	DT	B-NP	O
ethanol	ethanol	NN	I-NP	O
use	use	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
family	family	NN	I-NP	O
has	have	VBZ	B-VP	O
no	no	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
cardiomyopathy	cardiomyopathy	NN	B-NP	O
.	.	.	O	O

SIGNIFICANT	SIGNIFICANT	NNP	B-NP	O
LABS	LABS	NNP	I-NP	O
ON	ON	NNP	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Normal	Normal	JJ	B-NP	O
renal	renal	JJ	I-NP	O
function	function	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
BNP	BNP	NN	I-NP	O
of	of	IN	B-PP	O
1018	1018	CD	B-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
bandemia	bandemia	NN	B-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
shows	show	VBZ	B-VP	O
sinus	sinus	NN	B-NP	O
tachycardia	tachycardia	NN	I-NP	O
at	at	IN	B-PP	O
105	105	CD	B-NP	O
with	with	IN	B-PP	O
normal	normal	JJ	B-NP	O
axis	axis	NN	I-NP	O
,	,	,	O	O
widened	widen	VBN	B-VP	O
QRS	QRS	NNP	B-NP	B-protein
,	,	,	O	O
normal	normal	JJ	B-NP	O
PR	PR	NN	I-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
left	leave	VBD	B-VP	O
atrial	atrial	JJ	B-NP	O
enlargement	enlargement	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
no	no	DT	B-NP	O
change	change	NN	I-NP	O
since	since	IN	B-PP	O
1/25	1/25	CD	B-NP	O
Left	Left	JJ	I-NP	O
heart	heart	NN	I-NP	O
cath	cath	NN	I-NP	O
in	in	IN	B-PP	O
1990	1990	CD	B-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-ADJP	O
:	:	:	O	O
Ischemia	Ischemia	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
no	no	DT	B-NP	O
known	know	VBN	I-NP	O
CAD	CAD	NN	I-NP	B-protein
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
troponin	troponin	NN	I-NP	O
at	at	IN	B-PP	O
admission	admission	NN	B-NP	O
of	of	IN	B-PP	O
0.12	0.12	CD	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
subsequently	subsequently	RB	B-ADVP	O
went	go	VBD	B-VP	O
down	down	RB	B-ADVP	O
to	to	TO	B-PP	O
0.10	0.10	CD	B-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
assay	assay	NN	B-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
thought	think	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
right	right	JJ	B-NP	O
ventricular	ventricular	JJ	I-NP	O
strain	strain	NN	I-NP	O
with	with	IN	B-PP	O
volume	volume	NN	B-NP	O
overload	overload	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
aspirin	aspirin	NN	B-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
statin	statin	NN	I-NP	O
;	;	:	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
given	give	VBN	B-PP	O
her	her	PRP	B-NP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
CAD	CAD	NN	B-NP	B-protein
and	and	CC	O	O
a	a	DT	B-NP	O
normal	normal	JJ	I-NP	O
cholesterol	cholesterol	NN	I-NP	O
panel	panel	NN	I-NP	O
,	,	,	O	O
both	both	CC	O	O
aspirin	aspirin	NN	B-NP	O
and	and	CC	I-NP	O
statin	statin	NN	I-NP	O
were	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
.	.	.	O	O

Pump	Pump	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
presented	present	VBD	B-VP	O
as	as	IN	B-PP	O
``	``	``	O	O
cold	cold	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
wet	wet	JJ	I-ADJP	O
''	''	''	O	O
with	with	IN	B-PP	O
poor	poor	JJ	B-NP	O
forward	forward	NN	I-NP	O
flows	flow	VBZ	B-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
systolic	systolic	JJ	B-NP	O
dysfunction	dysfunction	NN	I-NP	O
and	and	CC	O	O
likely	likely	RB	B-NP	O
increased	increase	VBN	I-NP	O
SVR	SVR	NN	I-NP	B-protein
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
dobutamine	dobutamine	NN	B-NP	O
for	for	IN	B-PP	O
improved	improve	VBN	B-NP	O
inotrope	inotrope	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
put	put	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
Lasix	Lasix	NNP	I-NP	O
strip	strip	NN	I-NP	O
for	for	IN	B-PP	O
diuresis	diuresis	NN	B-NP	O
after	after	IN	B-PP	O
a	a	DT	B-NP	O
loading	loading	NN	I-NP	O
dose	dose	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
Isordil	Isordil	NN	B-NP	O
and	and	CC	I-NP	O
hydralazine	hydralazine	NN	I-NP	O
for	for	IN	B-PP	O
pre	pre	JJ	B-NP	O
and	and	CC	I-NP	O
afterload	afterload	JJ	I-NP	O
reduction	reduction	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
ACE	ACE	NN	I-NP	O
inhibitor	inhibitor	NN	I-NP	O
was	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
while	while	IN	B-SBAR	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
Lasix	Lasix	NNP	I-NP	O
strip	strip	NN	I-NP	O
.	.	.	O	O

Metolazone	Metolazone	NN	B-NP	O
also	also	RB	B-ADVP	O
was	be	VBD	B-VP	O
used	use	VBN	I-VP	O
to	to	TO	B-VP	O
improve	improve	VB	I-VP	O
diuresis	diuresis	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
digoxin	digoxin	NN	B-NP	O
with	with	IN	B-PP	O
level	level	NN	B-NP	O
checks	check	NNS	I-NP	O
every	every	DT	B-NP	O
three	three	CD	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
underwent	undergo	VBD	B-VP	O
an	an	DT	B-NP	O
echo	echo	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
an	an	DT	B-NP	O
EF	EF	NN	I-NP	B-protein
of	of	IN	B-PP	O
15	15	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
global	global	JJ	B-NP	O
akinesis	akinesis	NN	I-NP	O
with	with	IN	B-PP	O
moderate-to-severe	moderate-to-severe	JJ	B-NP	O
MR	MR	NN	I-NP	B-protein
,	,	,	O	O
moderate	moderate	JJ	B-NP	O
TR	TR	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
dyssynchrony	dyssynchrony	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
moderate-to-severe	moderate-to-severe	JJ	B-NP	O
RV	RV	NN	I-NP	O
dysfunction	dysfunction	NN	I-NP	O
.	.	.	O	O

Rhythm	Rhythm	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
telemetry	telemetry	NN	B-NP	O
,	,	,	O	O
especially	especially	RB	B-ADVP	O
given	give	VBN	B-PP	O
the	the	DT	B-NP	O
fact	fact	NN	I-NP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
ICD	ICD	NN	I-NP	B-protein
in	in	IN	B-PP	O
place	place	NN	B-NP	O
.	.	.	O	O

EP	EP	NN	B-NP	B-protein
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
and	and	CC	O	O
evaluated	evaluate	VBN	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
for	for	IN	B-PP	O
both	both	CC	O	O
an	an	DT	B-NP	O
ICD	ICD	NN	I-NP	B-protein
and	and	CC	I-NP	O
biventricular	biventricular	JJ	I-NP	O
pacer	pacer	NN	I-NP	O
given	give	VBN	B-VP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
dyssynchrony	dyssynchrony	NN	B-NP	O
on	on	IN	B-PP	O
echo	echo	NN	B-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
decided	decide	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
would	would	MD	B-VP	O
undergo	undergo	VB	I-VP	O
ICD	ICD	NN	B-NP	O
placement	placement	NN	I-NP	O
only	only	RB	B-ADVP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
creatinine	creatinine	NN	I-NP	O
was	be	VBD	B-VP	O
1.1	1.1	CD	B-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
monitored	monitor	VBN	I-VP	O
closely	closely	RB	B-ADVP	O
with	with	IN	B-PP	O
diuresis	diuresis	NN	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
normal	normal	JJ	I-NP	O
UA	UA	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Heme	Heme	NN	B-NP	B-protein
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
heparin	heparin	NN	B-NP	O
instead	instead	RB	B-PP	O
of	of	IN	I-PP	O
Coumadin	Coumadin	NN	B-NP	O
for	for	IN	B-PP	O
Chronicle	Chronicle	NNP	B-NP	O
device	device	NN	I-NP	O
lead	lead	NN	I-NP	O
thrombus	thrombus	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
PTT	PTT	NN	I-NP	O
goal	goal	NN	I-NP	O
of	of	IN	B-PP	O
60-80	60-80	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
platelets	platelet	NNS	I-NP	B-cell_type
dropped	drop	VBD	B-VP	O
from	from	IN	B-PP	O
222	222	CD	B-NP	B-DNA
to	to	TO	B-PP	I-DNA
166	166	CD	B-NP	I-DNA
during	during	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
and	and	CC	I-NP	O
tests	test	NNS	I-NP	O
were	be	VBD	B-VP	O
ordered	order	VBN	I-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
HIT	HIT	NN	I-NP	B-protein
antibody	antibody	NN	I-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
platelets	platelet	NNS	I-NP	B-cell_type
normalized	normalize	VBD	B-VP	O
,	,	,	O	O
but	but	CC	O	O
unfortunately	unfortunately	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
PF4	PF4	NN	I-NP	B-protein
was	be	VBD	B-VP	O
positive	positive	JJ	B-ADJP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
false	false	JJ	I-NP	O
positive	positive	JJ	I-NP	O
and	and	CC	O	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
confirmed	confirm	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
Heme	Heme	NNP	I-NP	O
consult	consult	NN	I-NP	O
.	.	.	O	O

Heme	Heme	NNP	B-NP	B-protein
recommended	recommend	VBD	B-VP	O
rechecking	rechecke	VBG	I-VP	O
the	the	DT	B-NP	O
PF4	PF4	NN	I-NP	B-protein
in	in	IN	B-PP	O
three	three	CD	B-NP	O
to	to	TO	I-NP	O
four	four	CD	I-NP	O
weeks	week	NNS	I-NP	O
and	and	CC	O	O
holding	hold	VBG	B-VP	O
heparin	heparin	NN	B-NP	B-protein
products	product	NNS	I-NP	I-protein
until	until	IN	B-SBAR	O
the	the	DT	B-NP	O
PF4	PF4	NN	I-NP	B-protein
was	be	VBD	B-VP	O
rechecked	rechecke	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
would	would	MD	B-VP	O
be	be	VB	I-VP	O
restarted	restart	VBN	I-VP	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
after	after	IN	B-PP	O
her	her	PRP$	B-NP	O
ICD	ICD	NN	I-NP	O
placement	placement	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Endocrine	Endocrine	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
insulin	insulin	NN	I-NP	O
and	and	CC	O	O
Lantus	Lantus	NN	B-NP	O
for	for	IN	B-PP	O
diabetes	diabetes	NN	B-NP	O
management	management	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

GI	GI	LS	B-LST	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
right	right	JJ	B-NP	O
upper	upper	JJ	I-NP	O
quadrant	quadrant	JJ	I-NP	O
pain	pain	NN	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
likely	likely	RB	B-ADJP	O
related	relate	VBN	I-ADJP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
congested	congested	JJ	I-NP	O
liver	liver	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
right	right	JJ	I-NP	O
upper	upper	JJ	I-NP	O
quadrant	quadrant	JJ	I-NP	O
ultrasound	ultrasound	NN	I-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
normal	normal	JJ	I-NP	O
liver	liver	NN	I-NP	O
with	with	IN	B-PP	O
thickened	thicken	VBN	B-NP	O
gall	gall	NN	I-NP	O
bladder	bladder	NN	I-NP	O
walls	wall	NNS	I-NP	O
and	and	CC	I-NP	O
ascites	ascite	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
symptoms	symptom	NNS	I-NP	O
were	be	VBD	B-VP	O
improved	improve	VBN	I-VP	O
with	with	IN	B-PP	O
diuresis	diuresis	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
Nexium	Nexium	NN	B-NP	O
for	for	IN	B-PP	O
prophylaxis	prophylaxis	NN	B-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Psych	Psych	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
citalopram	citalopram	NN	B-NP	O
and	and	CC	I-NP	O
Ativan	Ativan	NN	I-NP	O
for	for	IN	B-PP	O
depression	depression	NN	B-NP	O
and	and	CC	I-NP	O
anxiety	anxiety	NN	I-NP	O
.	.	.	O	O

Psych	Psych	NN	B-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
for	for	IN	B-PP	O
assistance	assistance	NN	B-NP	O
with	with	IN	B-PP	O
management	management	NN	B-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Musculoskeletal	Musculoskeletal	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
probenecid	probenecid	NN	B-NP	O
for	for	IN	B-PP	O
gout	gout	NN	B-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Prophylaxis	Prophylaxis	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
PPI	PPI	NN	B-NP	B-protein
and	and	CC	I-NP	O
heparin	heparin	NN	I-NP	O
until	until	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
HIT	HIT	NN	I-NP	O
positive	positive	JJ	B-ADJP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
Pneumoboots	Pneumoboot	NNS	B-NP	O
for	for	IN	B-PP	O
prophylaxis	prophylaxis	NN	B-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
To	To	TO	B-VP	O
be	be	VB	I-VP	O
determined	determine	VBN	I-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
2-0840228	2-0840228	CD	B-NP	O
HK	HK	NN	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
WISHUM	WISHUM	NNP	B-NP	O
,	,	,	O	O
TIMOTHY	TIMOTHY	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
ABRAHAMS	ABRAHAMS	NNP	B-NP	O
,	,	,	O	O
PHILIP	PHILIP	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
7971599	7971599	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
10/9/05	10/9/05	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
1/27/05	1/27/05	CD	B-NP	O

